Prudential shares steady as buyback ticks on and investors eye March results
19 January 2026
1 min read

Prudential shares steady as buyback ticks on and investors eye March results

London, Jan 19, 2026, 10:32 GMT — Regular session underway.

  • Prudential shares saw little movement in early London trading, as U.S. markets remained closed for Martin Luther King Jr. Day
  • Investors zeroed in on the group’s $1.2 billion buyback set for 2026, tracking daily repurchase updates closely
  • The next key event to watch is the full-year 2025 results, due March 19

Prudential shares dipped slightly in early London trade Monday as investors held back for more concrete company catalysts. The insurer just launched a fresh buyback programme this month. 1

The stock hovered near 1,182 pence, dipping just 0.5 pence below yesterday’s close of 1,182.5 pence. Intraday, it fluctuated between about 1,162 pence and 1,187.5 pence, based on delayed price data. 1

With Wall Street shut for Martin Luther King Jr. Day, the usual cross-Atlantic cues for global financial markets are absent, leaving UK investors to zero in on local activity and individual company news. 2

Prudential’s immediate boost has come from its capital returns plan. On January 6, the insurer announced it will start repurchasing up to $1.2 billion of shares in 2026, with the buyback set to continue through December. 3

Since then, it has consistently issued “transaction in own shares” notices linked to the buyback, showing a steady stream of repurchases carried out through JP Morgan and set aside for cancellation. 4

The broader investment case still hinges on Asia-driven growth. Prudential is zeroing in on life and health insurance, plus wealth products, across markets like Hong Kong and Southeast Asia. In these areas, new business volumes tend to react sharply to travel patterns, consumer confidence, and currency fluctuations.

A major concern for investors is execution risk: rising medical inflation could tighten margins in health sectors, regulatory shifts might change product economics, and any fresh swings in Asian equities or currency markets could impact fees and reported earnings.

Traders are closely monitoring if the buyback pace holds up during earnings season, as shifts in rate expectations and risk appetite can swiftly alter sector sentiment.

Prudential’s 2025 full-year results are lined up for March 19, with the release set for 06:00 HKT / 22:00 UK time on March 18, according to the company’s calendar. 5

Stock Market Today

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

7 February 2026
XRP fell about 5% Saturday to $1.42, extending a 22% weekly drop as thin liquidity and macro jitters drove sharp swings. Bitcoin rebounded above $70,000 after a brief plunge, while ether surged 12%. Ripple outlined plans for an “Institutional DeFi” roadmap, including a new lending protocol and permissioned DEX. The Federal Reserve held rates steady last week, with officials signaling caution on inflation.
Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
Reckitt Benckiser share price slips as buyback update lands and special dividend vote nears
Previous Story

Reckitt Benckiser share price slips as buyback update lands and special dividend vote nears

ICG plc share price slips nearly 2% as tariff jitters rattle Europe; Jan 21 update in focus
Next Story

ICG plc share price slips nearly 2% as tariff jitters rattle Europe; Jan 21 update in focus

Go toTop